Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (6)

Search Parameters:
Keywords = meibomitis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
8 pages, 233 KB  
Commentary
Dual Role of Cutibacterium acnes: Commensal Bacterium and Pathogen in Ocular Diseases
by Tomo Suzuki and Shigeru Kinoshita
Microorganisms 2024, 12(8), 1649; https://doi.org/10.3390/microorganisms12081649 - 12 Aug 2024
Cited by 2 | Viewed by 3584
Abstract
Microbiota present around the ocular surface, encompassing the eyelid skin, the conjunctival sac, and the meibomian glands, play a significant role in various inflammatory conditions associated with the ocular surface. Cutibacterium acnes (C. acnes), formerly, Propionibacterium acnes, is one of [...] Read more.
Microbiota present around the ocular surface, encompassing the eyelid skin, the conjunctival sac, and the meibomian glands, play a significant role in various inflammatory conditions associated with the ocular surface. Cutibacterium acnes (C. acnes), formerly, Propionibacterium acnes, is one of the most predominant commensal bacteria and its relative abundance declines with aging. However, it can act as both an infectious and an immunogenic pathogen. As an infectious pathogen, C. acnes has been reported to cause late onset endophthalmitis post-cataract surgery and infectious keratitis. On the other hand, it can trigger immune responses resulting in conditions such as phlyctenules in the cornea, chalazion in the meibomian glands, and granuloma formation in ocular sarcoidosis. This review explores the role of C. acnes in ocular inflammation, specifically highlighting its implications for diagnosis and management. Full article
(This article belongs to the Special Issue Cutibacterium acnes Infection and Immunity)
12 pages, 3013 KB  
Article
The Features and Treatment Effects on Keratoepitheliopathy for Meibomitis-Related Keratoconjunctivitis
by Yukiko Sonomura, Norihiko Yokoi, Aoi Komuro, Hiroaki Kato and Chie Sotozono
Diagnostics 2024, 14(5), 487; https://doi.org/10.3390/diagnostics14050487 - 23 Feb 2024
Cited by 1 | Viewed by 2849
Abstract
Meibomitis-related keratoconjunctivitis (MRKC) is characterized by meibomitis with corneal epithelial abnormalities, and can be divided into two types: MRKC accompanied with phlyctenular keratitis, and MRKC accompanied with keratoepitheliopathy that is similar to superficial punctate keratopathy (SPK). The purpose of this retrospective study was [...] Read more.
Meibomitis-related keratoconjunctivitis (MRKC) is characterized by meibomitis with corneal epithelial abnormalities, and can be divided into two types: MRKC accompanied with phlyctenular keratitis, and MRKC accompanied with keratoepitheliopathy that is similar to superficial punctate keratopathy (SPK). The purpose of this retrospective study was to investigate the characteristic features of keratoepitheliopathy and treatment outcomes for MRKC. This study involved 27 eyes of 18 MRKC patients (3 males and 15 females). National Eye Institute (NEI) scores and visual acuity were compared at pre and post treatment. All subjects were treated with a small-dose administration of clarithromycin. Keratoepitheliopathy characteristic to MRKC, yet different in appearance from SPK, was noted in 24 of the 27 eyes. Fluorescein staining revealed granular epithelial lesions generally larger than SPK that coexisted with small dark spots. In 17 eyes, keratoepitheliopathy was located within the pupillary zone, and the visual acuity in 12 eyes was less than 1.0. Our findings showed significant improvement in the NEI score in MRKC (p < 0.0001) and in visual acuity (p = 0.0157) post treatment, and the characteristic features of keratoepitheliopathy in MRKC that are often associated with decreased visual acuity were elucidated. The treatment of clarithromycin was found to be effective for MRKC with keratoepitheliopathy. Full article
(This article belongs to the Special Issue Diagnosis, Treatment and Management of Eye Diseases)
Show Figures

Figure 1

11 pages, 2362 KB  
Article
The Use of TECAR Therapy on Meibomitis Disease and Optical Nerve Flow
by Alfonso Tramontana, Giovanni Roberto Tedesco, Sergio Gurgone, Giuseppe Acri and Alessandro Meduri
Appl. Sci. 2023, 13(2), 1152; https://doi.org/10.3390/app13021152 - 14 Jan 2023
Viewed by 3959
Abstract
Meibomitis is an ocular disease which leads to a dysfunction of the meibomian glands. This ophthalmologic disease may cause severe pain and obvious vision loss. The therapeutic protocol used in the treatment of this pathology consists in local and systemic antibiotic therapy. The [...] Read more.
Meibomitis is an ocular disease which leads to a dysfunction of the meibomian glands. This ophthalmologic disease may cause severe pain and obvious vision loss. The therapeutic protocol used in the treatment of this pathology consists in local and systemic antibiotic therapy. The results obtained using this approach are scarce and, in many cases, result in adverse events. In this study, we propose an alternative and original approach using TECAR therapy in the treatments of meibomitis disease. The endogenous heat produced by the TECAR device produced beneficial effects from both a histological and anatomical point of view. Different parameters (TBUT, interferometry, tear meniscus height, meibography and OCTA) were evaluated before the TECAR treatments, immediately afterwards, and 15 days after the end of the treatments. The obtained results suggest a new possible use of TECAR therapy on ophthalmological patients, opening an innovative scenario in a non-invasive manner. Full article
Show Figures

Figure 1

8 pages, 693 KB  
Case Report
Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review
by Takashi Kojima, Murat Dogru, Eisuke Shimizu, Hiroyuki Yazu, Aya Takahashi and Jun Shimazaki
Diagnostics 2021, 11(4), 680; https://doi.org/10.3390/diagnostics11040680 - 9 Apr 2021
Cited by 3 | Viewed by 3374
Abstract
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at an early stage. An 85-year-old male had complaints of ocular dryness and redness and was diagnosed with meibomian gland dysfunction [...] Read more.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at an early stage. An 85-year-old male had complaints of ocular dryness and redness and was diagnosed with meibomian gland dysfunction with meibomitis. Despite an initial treatment with topical steroid and antibiotics, the meibomitis did not improve and the left eye developed scleritis and iridocyclitis. The patient was administered topical mydriatics and oral steroids. During follow-up, the patient developed left hearing difficulty and reported a darker urine. Urinalysis revealed microscopic hematuria. A blood test showed an elevated erythrocyte sedimentation rate, positivity for perinuclear anti-neutorophil cytoplasmic antibody, and elevations in blood urea nitrogen and serum creatinine. Nasal mucosal biopsy showed a non-necrotizing granulomatous inflammation. Renal biopsy revealed focal glomerulosclerosis. Cystoscopy and bladder wash followed by a planned transurethral resection revealed atypical cells and apical papillary tumors which were resected. Iridocyclitis and scleritis responded well to oral prednisolone with 0.1% topical betamethasone and prednisolone ointment. The patient is tumor free with no recurrences 24 months after resection. GPA may present atypically with meibomian gland dysfunction without showing representative clinical findings. Early detection and treatment are essential for visual recovery. Full article
(This article belongs to the Special Issue Differential Diagnosis for Dry Eye)
Show Figures

Figure 1

6 pages, 2507 KB  
Case Report
A Case of Sebaceous Adenitis and Concurrent Meibomian Gland Dysfunction in a Dog
by Roberta Sartori and Claudio Peruccio
Vet. Sci. 2020, 7(2), 37; https://doi.org/10.3390/vetsci7020037 - 2 Apr 2020
Cited by 10 | Viewed by 7332
Abstract
Sebaceous adenitis and concurrent meibomian gland dysfunction (MGD) were diagnosed in a two-year-old mongrel dog presenting with hypotrichosis, exfoliative dermatitis and blepharitis. Diagnosis of sebaceous adenitis was based on history, clinical signs, the histological demonstration of multifocal lymphohistiocytic and neutrophilic inflammation targeting the [...] Read more.
Sebaceous adenitis and concurrent meibomian gland dysfunction (MGD) were diagnosed in a two-year-old mongrel dog presenting with hypotrichosis, exfoliative dermatitis and blepharitis. Diagnosis of sebaceous adenitis was based on history, clinical signs, the histological demonstration of multifocal lymphohistiocytic and neutrophilic inflammation targeting the sebaceous glands and sebaceous glands loss. MGD was diagnosed by non-contact infrared meibography followed by tear film lipid layer interferometric evaluation. Ciclosporin and sebolytic shampoos controlled the dermatological condition, while doxycycline, warm compresses, palpebral massages and tobramycin/dexamethasone ointment controlled the blepharitis. This case report should stimulate clinicians to investigate MGD in dogs suffering from sebaceous adenitis, because the meibomian and sebaceous glands share similar anatomy and physiology. Full article
Show Figures

Figure 1

10 pages, 2053 KB  
Article
A Novel Model of Meibomian Gland Dysfunction Induced with Complete Freund’s Adjuvant in Rabbits
by Hideki Miyake, Tomoko Oda, Osamu Katsuta, Masaharu Seno and Masatsugu Nakamura
Vision 2017, 1(1), 10; https://doi.org/10.3390/vision1010010 - 9 Feb 2017
Cited by 21 | Viewed by 27038
Abstract
A novel meibomian gland dysfunction (MGD) model induced by the injection of complete Freund’s adjuvant (CFA) in rabbits was developed to facilitate the understanding of the pathophysiology of MGD with meibomitis. In addition, we sought to evaluate treatment with steroid eye drops in [...] Read more.
A novel meibomian gland dysfunction (MGD) model induced by the injection of complete Freund’s adjuvant (CFA) in rabbits was developed to facilitate the understanding of the pathophysiology of MGD with meibomitis. In addition, we sought to evaluate treatment with steroid eye drops in this model. Male Japanese white rabbits were subcutaneously injected with CFA into the upper eyelid margin. The eyelid margins of the rabbits were chronologically observed through slit lamp examination. The development of meibomitis was assessed through histopathology. We evaluated the effects of topically applied tobramycin/dexamethasone (Tob/Dex) eye drops on the plugged orifices and telangiectasia. After the injection of CFA, slit lamp examination revealed markedly plugged orifices, telangiectasia around the orifices and a toothpaste-like meibum, as compared with the normal eyelids. Histopathology revealed granulation tissue with infiltration of inflammatory cells, hyperkeratinization of the ductal epithelium, and cystic dilatation of ducts in the meibomian gland. The orifices were plugged with a proteinaceous substance. Tob/Dex eye drops significantly suppressed the plugging and telangiectasia around the orifices. Through the injection of CFA, we successfully established a novel rabbit MGD that mimics the symptoms observed in humans meibomitis. This model should be useful in the evaluation of the efficacy of drug candidates. Full article
Show Figures

Figure 1

Back to TopTop